丹麦心衰患者处方差异:全国纵向队列研究
结果发现女性、高龄、独居和非丹麦本土裔与两类药物处方缺失相关,且ARNi处方存在显著社会经济梯度。
要点
- 女性、高龄、独居及非本土裔心衰患者ARNi和SGLT2i处方率更低。
- ARNi处方存在显著社会经济梯度,低教育、低收入者处方更少。
- 在全民医疗体系中仍存在救命药物处方的显著差异。
核心结论
- 在全民医疗体系中,心衰患者ARNi和SGLT2i处方存在显著差异,与低教育、低收入及多项人口学特征相关。
主要发现
- 女性、高龄、独居、非丹麦本土裔或其后代与ARNi和SGLT2i处方缺失相关,ARNi的HR范围为0.31(95%CI 0.28-0.36)至0.86(95%CI 0.80-0.93),SGLT2i为0.49(95%CI 0.41-0.58)至0.93(95%CI 0.72-1.20)。
- ARNi和SGLT2i处方均呈现社会梯度,其中ARNi的梯度具有统计学显著性。
临床怎么用
- 临床处方ARNi和SGLT2i时应关注女性、高龄、独居及非本土裔患者,避免治疗不足。
- 需关注低教育、低收入患者,减少社会经济因素导致的处方差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Angiotensin receptor-neprilysin inhibitors (ARNi) and sodium-glucose co-transporter 2 inhibitors (SGLT2i) have a Class I indication in the European Society of Cardiology's guidelines for the diagnosis and treatment of acute and chronic heart failure due to benefits in symptom management, rehospitalization rates, and mortality in heart failure. The aim of this study was to investigate demographic, geographic and socioeconomic disparities in prescriptions for ARNi and SGLT2i for heart failure patients in a universal healthcare system. METHODS: We used national registers to identify all Danish heart failure patients who were diagnosed on or after the updated clinical guidelines by the European Society of Cardiology (14 July 2016 for ARNi and 27 August 2021 for SGLT2i). Patients were followed until redemption of prescription, emigration, death or censoring on 30 June 2022, whichever came first. The Aalen-Johansen estimator and Cox proportional hazard models were used for individual analysis of ARNi (n=43 625) and SGLT2i (n=2819). RESULTS: The following factors were associated with lack of prescriptions for ARNi and SGLT2i: being women, older age, living alone and being non-native Danish or descendant. HRs ranged from 0.31 (95% CI 0.28 to 0.36) to 0.86 (95% CI 0.80 to 0.93) for ARNi and 0.49 (95% CI 0.41 to 0.58) to 0.93 (95% CI 0.72 to 1.20) for SGLT2i. Prescriptions for both ARNi and SGLT2i showed a social gradient, with the gradient for ARNi being statistically significant. CONCLUSIONS: Substantial disparity was found in prescriptions for the potentially life-saving medications, with lack of prescriptions being associated with lower education, lower income and several demographic characteristics.
引用
- Christensen, Hyldgård, Madelaire, et al. Disparities in prescriptions among Danish heart failure patients: a national longitudinal cohort study. Heart. 2025. PMID: 40348409. doi:10.1136/heartjnl-2024-325562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。